BackLi Kang Biomedical , Ltd. Overview

Li Kang Biomedical , Ltd. Total Current Liabilities

Li Kang Biomedical , Ltd.'s total current liabilities is $240M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$241.29M
↑ 6.04% YoYΔ $13.74M vs prior year quarter

Peer trimmed avg / median

Loading

Li Kang Biomedical , Ltd. Total Current Liabilities History

Loading

Li Kang Biomedical , Ltd. vs. peers: Total Current Liabilities Comparison

Loading

Li Kang Biomedical , Ltd. Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Li Kang Biomedical , Ltd. (6242.TWO) FAQ

The latest total current liabilities for 6242.TWO is $240M as of June 2026. That compares with $230M in the prior-year period — up 6.0% year over year. Investors often review this figure alongside Li Kang Biomedical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6242.TWO's total current liabilities moved from $230M to $240M — a 6.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Li Kang Biomedical , Ltd.'s operating scale or balance-sheet position.

A total current liabilities figure of $240M for 6242.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6242.TWO's total current liabilities ($240M), review year-over-year change from $230M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.